# Bristol Myers Squibb: portfolio, investments and team > Bristol Myers Squibb is a vc firm based in United States. 15 investments on record, 2 in the last 12 months, latest Oct 2026. Source: https://millionrounds.com/fund/bristol-myers-squibb (Millionrounds; every figure on the page links to its filing or article) United States · [Investor](https://millionrounds.com/investors) # Bristol Myers Squibb Last cheque observed Oct 2026; 15 cheques on record. Email Deploying now VC firm Seed Series A Series B Pharma Medicine Drugs Follow Bristol Myers Squibb and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fbristol-myers-squibb) Deploying now **100%** of best year **2** **cheques in 12 months**, 15 on record Since the last cheque **7** days **00** hrs **00** min **00** sec Median round **$75M** Rounds led **1 of 15** Mostly in **United States, 67%** Pitch Bristol Myers Squibb ## Bristol Myers Squibb highlights - 01 2 cheques in the last 12 months - 02 Mostly Series B and Series C: 67% of its rounds - 03 Led 1 rounds ## What they do > Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases. From their own website - **Type:** VC firm (from a list, unverified) - **Cheque size:** Not stated - **Stages:** Seed Series A Series B Growth - **Sectors:** Pharma Medicine Drugs - **Based in:** Lawrence Township, United States - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **15 appearances** - **2026** 2 rounds - **Oct** **[Pathos AI](https://millionrounds.com/company/pathos-ai)** Series E · US · Wowtale **$237M** *Led* - **Jun** **[SonoThera](https://millionrounds.com/company/sonothera)** Series B · US · Ventureburn **$125M** With 10 others - **2025** 1 round - **May** **[GlycoEra](https://millionrounds.com/company/glycoera)** Series B · CH · TechStartups **$130M** With 8 others - **2024** 1 round - **Mar** **[Capstan Therapeutics](https://millionrounds.com/company/capstan-therapeutics)** Series B · US · Firms' own news pages **$175M** With 15 others - **2023** 1 round - **Oct** **[AstronauTx](https://millionrounds.com/company/astronautx)** Series A · GB · UCL Technology Fund **$61M** With 7 others - **2019** 2 rounds - **Nov** **[PathAI](https://millionrounds.com/company/pathai)** US · FinSMEs **$75M** With 1 other - **May** **[Vedanta Biosciences](https://millionrounds.com/company/vedanta-biosciences)** Series C · US · Businesswire **$46M** With 8 others - **2018** 2 rounds - **Dec** **[Vedanta Biosciences](https://millionrounds.com/company/vedanta-biosciences)** Series C · US · FinSMEs **$27M** With 5 others - **Oct** **[Galecto](https://millionrounds.com/company/galecto)** Series C · DK · FinSMEs **$90M** With 9 others - **2017** 4 rounds - **May** **[Cardior Pharmaceuticals](https://millionrounds.com/company/cardior-pharmaceuticals)** Series A · DE · FinSMEs **$16M** With 4 others - **Mar** **[Grail](https://millionrounds.com/company/grail)** Series B · US · FinSMEs **$900M** With 7 others - **Jan** **[Personal Genome Disgnostics](https://millionrounds.com/company/personal-genome-disgnostics)** Series B · US · FinSMEs **$75M** With 4 others - **Jan** **[Enterome](https://millionrounds.com/company/enterome)** Series D · FR · FinSMEs **$39M** With 6 others - **2009** 2 rounds - **Oct** **[CareDx](https://millionrounds.com/company/caredx)** Venture · US · onbiovc.com **$14M** With 6 others - **Aug** **[CareDx](https://millionrounds.com/company/caredx)** Series F · US · sanjose.bizjournals.com **$14M** With 7 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team We hold **11** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## What the register says From the firm's own filings with the SEC, which it must file accurately by law **5+** funds on file numbered funds in its name ## What they claim to have backed From their own portfolio page (on their website) **0** of 1 we have independently watched raise Medical information online Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded. ## Companies it bought Acquisitions by the firm itself **[Cardioxyl Pharmaceuticals](https://millionrounds.com/company/cardioxyl-pharmaceuticals)** **$2.0B** Nov 2015 **[Flexus Biosciences](https://millionrounds.com/company/flexus-biosciences)** **$1.3B** Feb 2015 **[Galecto Biotech](https://millionrounds.com/company/galecto-biotech)** **$444M** Nov 2014 **f-star Biotech** **$475M** Oct 2014 **[iPierian](https://millionrounds.com/company/ipierian)** **$175M** Apr 2014 **[Inhibitex](https://millionrounds.com/company/inhibitex)** **$2.5B** Jan 2012 **[Amira Pharmaceuticals](https://millionrounds.com/company/amira-pharmaceuticals)** **$325M** Jul 2011 **[Adnexus](https://millionrounds.com/company/adnexus)** **$415M** Aug 2010 **Medarex** **$2.4B** Jul 2009 **[Kosan Biosciences](https://millionrounds.com/company/kosan-biosciences)** **$190M** May 2008 **[Adnexus](https://millionrounds.com/company/adnexus)** **$415M** Sept 2007 ## The cheque Seed Series A Series B Median round joined **$75M** the round, not its cheque Led 1 of 15 rounds **7%** - **Sole investor:** Never alone - **Last cheque:** Oct 2026 Rounds by stage said on their site - Series B said *5* - Series C *3* - Series A said *2* - Series F *1* - Venture *1* - Seed said *-* - Growth said *-* Cheques by month Led Joined Nov 2023 Oct 2026 Often in the room with - [Seventure](https://millionrounds.com/fund/seventure) 3 - [Alexandria Real Estate Equities](https://millionrounds.com/fund/alexandria) 2 - [Burrill & Company](https://millionrounds.com/fund/burrill-and-company) 2 - [Eli Lilly](https://millionrounds.com/fund/eli-lilly) 2 - [Gates Foundation](https://millionrounds.com/fund/bill-and-melinda-gates-foundation) 2 - [Integral Capital Partners](https://millionrounds.com/fund/integral-capital-partners) 2 **Pitching Bristol Myers Squibb?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Bristol Myers Squibb. A count of rooms they were both in, not a relationship either has claimed. [**Seventure** VC firm **3** rounds together](https://millionrounds.com/fund/seventure)[**Alexandria Real Estate Equities** VC firm **2** rounds together](https://millionrounds.com/fund/alexandria)[**Burrill & Company** VC firm **2** rounds together](https://millionrounds.com/fund/burrill-and-company)[**Eli Lilly** Corporate VC **2** rounds together](https://millionrounds.com/fund/eli-lilly)[**Gates Foundation** Institutional LP **2** rounds together](https://millionrounds.com/fund/bill-and-melinda-gates-foundation)[**Integral Capital Partners** Growth equity **2** rounds together](https://millionrounds.com/fund/integral-capital-partners)[**Invesco Asset** Growth equity **2** rounds together](https://millionrounds.com/fund/invesco-asset)[**Kleiner Perkins Caufield & Byers** VC firm **2** rounds together](https://millionrounds.com/fund/kleiner-perkins-caufield-and-byers)[**Merck Global Health Innovation Fund** Corporate VC **2** rounds together](https://millionrounds.com/fund/merck-global-health-innovation-fund)[**Novartis Venture Fund** Corporate VC **2** rounds together](https://millionrounds.com/fund/novartis-venture-fund)[**OrbiMed** Private equity **2** rounds together](https://millionrounds.com/fund/orbimed)[**Perceptive Advisors** Asset manager **2** rounds together](https://millionrounds.com/fund/perceptive-advisors) ## Recently backed The latest companies Bristol Myers Squibb put money into. [**SonoThera** $125M · Jun 2026](https://millionrounds.com/company/sonothera)[**GlycoEra** $130M · May 2025](https://millionrounds.com/company/glycoera)[**AstronauTx** $61M · Oct 2023](https://millionrounds.com/company/astronautx)[**PathAI** $75M · Nov 2019](https://millionrounds.com/company/pathai)[**Vedanta Biosciences** $46M · May 2019](https://millionrounds.com/company/vedanta-biosciences)[**Galecto** $90M · Oct 2018](https://millionrounds.com/company/galecto) ## Quick answers about Bristol Myers Squibb ### What does Bristol Myers Squibb invest in? Bristol Myers Squibb invests most often at Series B and Series C (67% of the rounds on record), in sectors such as Pharma, Medicine and Drugs. ### How active is Bristol Myers Squibb? 15 investments on record, 2 of them in the last 12 months, and it led 1. The most recent was in Oct 2026. ### What has Bristol Myers Squibb invested in recently? Its most recent investments on record: Pathos AI (Series E, Oct 2026), SonoThera (Series B, Jun 2026) and GlycoEra (Series B, May 2025). ### How big are Bristol Myers Squibb's cheques? The median round it joins is $75M. ### Does Bristol Myers Squibb lead rounds? Sometimes: it led 1 of its 15 investments on record (7%). ### Where does Bristol Myers Squibb invest? Most of the companies it backs are in the United States (67%), Switzerland (7%) and the United Kingdom (7%). ### Is Bristol Myers Squibb investing now? Yes: it is actively investing, with 2 investments in the last 12 months. ### Who does Bristol Myers Squibb invest alongside? Most often Seventure (3 rounds together), Alexandria Real Estate Equities (2 rounds together) and Burrill & Company (2 rounds together). ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=bristol-myers-squibb) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=bristol-myers-squibb)